In the BioHarmony Drug Report Database
Clobetasol
Clobex, Impeklo, Impoyz, Olux, Olux E, Temovate, Temovate E (clobetasol propionate) is a small molecule pharmaceutical. Clobetasol propionate was first approved as Clobex on 1985-12-27. It is used to treat dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, and inflammation amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor. Clobetasol propionate’s patents are valid until 2035-03-11 (FDA).
Trade Name
|
Clobex, Impeklo, Impoyz, Olux, Olux E, Temovate, Temovate E |
|---|---|
Common Name
|
clobetasol propionate |
ChEMBL ID
|
CHEMBL1159650 |
Indication
|
dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, scalp dermatoses |
Drug Class
|
Image (chem structure or protein)